Simultaneous screening for three correlated lipids in the VA HDL intervention trial

Journal of Clinical Epidemiology

Volumn 52, Issue 7, 1999, Pages 685-693

  Iwane, Marika K ^a,b   Wittes, Janet ^b   Collins, Dorothea E ^a   Rubins, Hanna B ^c  

^a VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^b University of Iowa   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Coronary heart disease; HDL cholesterol; LDL cholesterol; Lipids; Screening

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; TRIACYLGLYCEROL;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DOUBLE BLIND PROCEDURE; HUMAN; LIPID ANALYSIS; METHODOLOGY; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCREENING; SIMULATION;

AGED; ANTILIPEMIC AGENTS; CHOLESTEROL, HDL; CHOLESTEROL, LDL; COMPUTER SIMULATION; CORONARY DISEASE; DOUBLE-BLIND METHOD; GEMFIBROZIL; HOSPITALS, VETERANS; HUMANS; MALE; MASS SCREENING; TRIGLYCERIDES; UNITED STATES;

EID: 0033050433     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-4356(99)00031-1     Document Type: Article

References (10)

1. Stampfer M.J., Sacks M.D., Salvini S., Willett W.C., Hennekens C.H. A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction. N Engl J Med. 325:1991;373-381.
2. Gordon D.J., Probstfield J.L., Garrison R.J., Neaton J.D., Castelli W.P., Knoke J.D.et al. High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies Circulation. 79:1989;8-15.
3. Rubins H.B., Robins S.J., Collins D., Iranmanesh A., Wilt T.J., Mann D.et al. Distribution of lipids in 8,500 men with coronary artery disease. Am J Cardiol. 75:1995;1196-1201.
4. Rubins H.B., Iwane M.K., Robins S.J., Boden W.E., Elam M.B., Fye C.L.et al. Rationale and design of the Department of Veterans Affairs high-density lipoprotein cholesterol intervention trial (HIT) for secondary prevention of coronary artery disease in men with low high-density lipoprotein cholesterol and desirable low-density lipoprotein cholesterol. Am J Cardiol. 71:1993;45-52.
5. Friedewald W.T., Levy R.I., Frederickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultra-centrifuge. Clin Chem. 18:1972;499-508.
6. Davis CE, Gordon D, La Rosa J, Wood PDS, Halperin M. Correlations of plasma high-density lipoprotein cholesterol levels with other plasma lipids and lipoprotein concentraions: The Lipid Research Clinics Program Prevalence study. Circulation 1980; 62: IV-24-IV-30.
7. Rubins H.B., Schectman G., Wilt T.J., Iwane M.K. Distribution of lipid phenotypes in community-living men with coronary heart disease. Arch Intern Med. 152:1992;2412-2416.
8. Parisi A., Folland E.D., Hartigan P. A comparison of angioplasty with medical therapy in the treatment of single-vessel coronary artery disease. Veterans Affairs ACME Investigators. N Engl J Med. 326:1992;10-16.
9. Chaitman B., Rosen A.D., Williams D.O., Bourassa M.G., Aguirre F.V., Pitt B.et al. Myocardial infarction and cardiac mortality in the Bypass Angioplasty Revascularization Investigation (BARI) trial. Circulation. 96:1997;2162-2170.
10. Rubins H.B., Robins S.J. Effect of reduction of plasma triglycerides with gemfibrozil on high-density-lipoprotein-cholesterol concentrations. J Intern Med. 231:1992;421-426.